Skip to content
The Nexus
DossierENTITY

Yasukawa

Coverage of Yasukawa in the Nexus archive.

Earliest in view: May 27 · 01:10 UTCMost recent: May 27 · 01:10 UTC
Co-mentioned in this coverage
Astellas Pharma Inc.organization1Europeplace1Tokyo, Japanplace1experimental drugtopic1hot flashestopic1menopausal womentopic1
Recent coverage
  • BUSINESSMay 27 · 01:10 UTCBLOOMBERG
    Astellas Pharma Shares Fall After Unveiling Five-Year Plan

    Astellas Pharma Inc. announced a five-year plan and plans to seek European regulatory review for an experimental drug targeting menopausal hot flashes, leading to a decline in its shares. The company's headquarters is in Tokyo, Japan, and the initiative was mentioned by Yasukawa.